Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000891618-04-000355
Filing Date
2004-01-29
Accepted
2004-01-28 21:30:10
Documents
1
Group Members
DANIEL K. TURNER, IIIHOWARD D. PALEFSKYMONTREUX EQUITY MANAGEMENT II SBIC, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f96002sc13d.htm SC 13D 155517
  Complete submission text file 0000891618-04-000355.txt   157583
Mailing Address 3260 WHIPPLE ROAD UNION CITY CA 94587-1217
Business Address 3260 WHIPPLE ROAD UNION CITY CA 94587-1217 5104000700
QUESTCOR PHARMACEUTICALS INC (Subject) CIK: 0000891288 (see all company filings)

EIN.: 330476164 | State of Incorp.: CA | Fiscal Year End: 0731
Type: SC 13D | Act: 34 | File No.: 005-43062 | Film No.: 04550517
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 SAND HILL ROAD SUITE 215 MENLO PARK CA 94025
Business Address
MONTREUX EQUITY PARTNERS II SBIC LP (Filed by) CIK: 0001277894 (see all company filings)

EIN.: 770530710 | State of Incorp.: CA | Fiscal Year End: 1231